Lucid

Our DiaComp pilot grant was selected for funding

Our pilot award to DiaComp was selected for funding! The goal of this pilot study is to test novel podocyte protective compounds that emerged from a phenotypic screen in an animal model of diabetic kidney disease


10 views0 comments

Recent Posts

See All

Our grant application (Ali, Lemmon, Bixby, Lee, Arizala) to the Blueprint Neurotherapeutics network was selected for funding! The goal of this proposal is to generate a therapeutic candidate (spinal c

Our State of Florida grant with Drs. Jonathan Schatz (PI), Yangbo Feng, and Stephan Schuerer was selected for funding! The goal of this grant is to validate a novel drug target that we discovered for